{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:12:35Z","timestamp":1792782755802,"version":"4.5.0"},"reference-count":169,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T00:00:00Z","timestamp":1551139200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National Research Foundation of South Africa","award":["105867"],"award-info":[{"award-number":["105867"]}]},{"name":"Medical Research Council","award":["416040"],"award-info":[{"award-number":["416040"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s00392-019-01441-x","type":"journal-article","created":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T10:55:34Z","timestamp":1551178534000},"page":"831-846","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["Role of pregnancy hormones and hormonal interaction on the maternal cardiovascular system: a literature review"],"prefix":"10.1007","volume":"108","author":[{"given":"Vitaris","family":"Kodogo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feriel","family":"Azibani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Sliwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,26]]},"reference":[{"key":"1441_CR1","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/cvr\/cvu013","volume":"101","author":"E Chung","year":"2014","unstructured":"Chung E, Leinwand LA (2014) Pregnancy as a cardiac stress model. Cardiovasc Res 101:561\u2013570. \n                    https:\/\/doi.org\/10.1093\/cvr\/cvu013","journal-title":"Cardiovasc Res"},{"key":"1441_CR2","doi-asserted-by":"publisher","first-page":"89","DOI":"10.5830\/CVJA-2016-021","volume":"27","author":"P Soma-pillay","year":"2016","unstructured":"Soma-pillay P, Nelson-piercy C, Tolppanen H, Mebazaa A (2016) Physiological changes in pregnancy. Cardiovasc J AFRICA 27:89\u201394. \n                    https:\/\/doi.org\/10.5830\/CVJA-2016-021","journal-title":"Cardiovasc J AFRICA"},{"key":"1441_CR3","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1161\/CIRCULATIONAHA.114.009029","volume":"10","author":"M Sanghavi","year":"2014","unstructured":"Sanghavi M, Rutherford JD (2014) Cardiovascular physiology of pregnancy. Circ AHA 10:1003\u20131008. \n                    https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.114.009029","journal-title":"Circ AHA"},{"key":"1441_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11906-017-0774-6","volume":"19","author":"G Osol","year":"2017","unstructured":"Osol G, Ko NL, Mandal\u00e0 M (2017) Altered endothelial nitric oxide signaling as a paradigm for maternal vascular maladaptation in preeclampsia. Curr Hypertens Rep 19:1\u201312. \n                    https:\/\/doi.org\/10.1007\/s11906-017-0774-6","journal-title":"Curr Hypertens Rep"},{"key":"1441_CR5","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1515\/hmbci-2013-0048","volume":"18","author":"RL Dos Santos","year":"2014","unstructured":"Dos Santos RL, Da Silva FB, Ribeiro RF, Stefanon I (2014) Sex hormones in the cardiovascular system. Horm Mol Biol Clin Investig 18:89\u2013103. \n                    https:\/\/doi.org\/10.1515\/hmbci-2013-0048","journal-title":"Horm Mol Biol Clin Investig"},{"key":"1441_CR6","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.bpobgyn.2008.06.005","volume":"22","author":"A Carlin","year":"2008","unstructured":"Carlin A (2008) Physiological changes of pregnancy and monitoring. Res Clin Obstet Gynaecol 22:801\u2013823. \n                    https:\/\/doi.org\/10.1016\/j.bpobgyn.2008.06.005","journal-title":"Res Clin Obstet Gynaecol"},{"key":"1441_CR7","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/GCO.0b013e328359826f","volume":"24","author":"K Melchiorre","year":"2012","unstructured":"Melchiorre K, Sharma R, Thilaganathan B (2012) Cardiac structure and function in normal pregnancy. Curr Opin Obstet Gynecol 24:413\u2013421. \n                    https:\/\/doi.org\/10.1097\/GCO.0b013e328359826f","journal-title":"Curr Opin Obstet Gynecol"},{"key":"1441_CR8","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1136\/heartjnl-2015-308476","volume":"102","author":"VL Meah","year":"2016","unstructured":"Meah VL, Cockcroft JR, Backx K et al (2016) Cardiac output and related haemodynamics during pregnancy: a series of meta-analyses. Heart 102:518\u2013526. \n                    https:\/\/doi.org\/10.1136\/heartjnl-2015-308476","journal-title":"Heart"},{"key":"1441_CR9","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.recesp.2011.07.009.The","volume":"64","author":"ME Halla","year":"2011","unstructured":"Halla ME, Eric M, George JPG (2011) The heart during pregnancy. Rev Esp Cardiol 64:1045\u20131050. \n                    https:\/\/doi.org\/10.1016\/j.recesp.2011.07.009.The","journal-title":"Rev Esp Cardiol"},{"key":"1441_CR10","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1093\/cvr\/cvu009","volume":"101","author":"LX Liu","year":"2014","unstructured":"Liu LX, Arany Z (2014) Maternal cardiac metabolism in pregnancy. Cardiovasc Res 101:545\u2013553. \n                    https:\/\/doi.org\/10.1093\/cvr\/cvu009","journal-title":"Cardiovasc Res"},{"key":"1441_CR11","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1161\/CIRCULATIONAHA.114.009029","volume":"130","author":"M Sanghavi","year":"2014","unstructured":"Sanghavi M, Rutherford JD (2014) Cardiovascular physiology of pregnancy. Circulation 130:1003\u20131008. \n                    https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.114.009029","journal-title":"Circulation"},{"key":"1441_CR12","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1161\/HYPERTENSIONAHA.115.06667","volume":"67","author":"K Melchiorre","year":"2016","unstructured":"Melchiorre K, Sharma R, Khalil A, Thilaganathan B (2016) Maternal cardiovascular function in normal pregnancy: evidence of maladaptation to chronic volume overload. Hypertension 67:754\u2013762. \n                    https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.115.06667","journal-title":"Hypertension"},{"key":"1441_CR13","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0029-7844(97)85765-1","volume":"89","author":"GJ Gilson","year":"1997","unstructured":"Gilson GJ, Samaan S, Crawford MH et al (1997) Changes in hemodynamics, ventricular remodeling, and ventricular contractility during normal pregnancy: a longitudinal study. Obstet Gynecol 89:957\u2013962. \n                    https:\/\/doi.org\/10.1016\/S0029-7844(97)85765-1","journal-title":"Obstet Gynecol"},{"key":"1441_CR14","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1002\/uog.12296","volume":"41","author":"ME Estensen","year":"2013","unstructured":"Estensen ME, Beitnes JO, Grindheim G et al (2013) Altered maternal left ventricular contractility and function during normal pregnancy. Ultrasound Obstet Gynecol 41:659\u2013666. \n                    https:\/\/doi.org\/10.1002\/uog.12296","journal-title":"Ultrasound Obstet Gynecol"},{"key":"1441_CR15","doi-asserted-by":"publisher","first-page":"284","DOI":"10.5935\/abc.20150007","volume":"104","author":"F Rebelo","year":"2015","unstructured":"Rebelo F, Farias DR, Mendes RH, Schl\u00fcsselal MM, Kac G (2015) Blood pressure variation throughout pregnancy according to early gestational BMI: A Brazilian Cohort. Arq Bras Cardiol 104:284\u2013291. \n                    https:\/\/doi.org\/10.5935\/abc.20150007","journal-title":"Arq Bras Cardiol"},{"key":"1441_CR16","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1067\/mob.2000.107928","volume":"183","author":"National High Blood Pressure Education Program Working Group","year":"1990","unstructured":"National High Blood Pressure Education Program Working Group (1990) Report on high blood pressure in pregnancy. Am J Obstet Gynecol 183:1691\u20131712. \n                    https:\/\/doi.org\/10.1067\/mob.2000.107928","journal-title":"Am J Obstet Gynecol"},{"key":"1441_CR17","unstructured":"Gifford R, August P, Cunningham G et al (2000) National High Blood Pressure Education Working Group report on high blood pressure in pregnancy. Natl Institutes Heal NIH Publ no 00-3029, pp\u00a03\u20135"},{"key":"1441_CR18","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0002-8703(97)70247-3","volume":"133","author":"T Geva","year":"1997","unstructured":"Geva T, Mauer MB, Striker L et al (1997) Effects of physiologic load of pregnancy on left ventricular contractility and remodeling. Am Heart J 133:53\u201359. \n                    https:\/\/doi.org\/10.1016\/S0002-8703(97)70247-3","journal-title":"Am Heart J"},{"key":"1441_CR19","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1161\/01.CIR.99.4.511","volume":"1","author":"A Mesa","year":"1999","unstructured":"Mesa A, Jessurun C, Hernandez A et al (1999) Left ventricular diastolic function in normal human pregnancy. Circulation 1:511\u2013517","journal-title":"Circulation"},{"key":"1441_CR20","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1136\/hrt.68.12.540","volume":"68","author":"S Hunter","year":"1992","unstructured":"Hunter S, Robson SC (1992) Adaptation of the maternal heart in pregnancy. Heart 68:540\u2013543. \n                    https:\/\/doi.org\/10.1136\/hrt.68.12.540","journal-title":"Heart"},{"key":"1441_CR21","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1093\/cvr\/cvx192","volume":"113","author":"M Sampaolesi","year":"2017","unstructured":"Sampaolesi M, Van Calsteren K (2017) Physiological and pathological gestational cardiac hypertrophy: what can we learn from rodents? Cardiovasc Res 113:1533\u20131535. \n                    https:\/\/doi.org\/10.1093\/cvr\/cvx192","journal-title":"Cardiovasc Res"},{"key":"1441_CR22","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1093\/cvr\/cvu012","volume":"101","author":"K Sliwa","year":"2014","unstructured":"Sliwa K, B\u00f6hm M (2014) Incidence and prevalence of pregnancy-related heart disease. Cardiovasc Res 101:554\u2013560. \n                    https:\/\/doi.org\/10.1093\/cvr\/cvu012","journal-title":"Cardiovasc Res"},{"key":"1441_CR23","first-page":"192","volume":"2","author":"J Li","year":"2012","unstructured":"Li J, Umar S, Amjedi M et al (2012) New frontiers in heart hypertrophy during pregnancy. Am J Cardiovasc Dis 2:192\u2013207","journal-title":"Am J Cardiovasc Dis"},{"key":"1441_CR24","doi-asserted-by":"publisher","first-page":"23905","DOI":"10.3390\/ijms161023905","volume":"16","author":"MC Gongora","year":"2015","unstructured":"Gongora MC, Wenger NK (2015) Cardiovascular complications of pregnancy. Int J Mol Sci 16:23905\u201323928. \n                    https:\/\/doi.org\/10.3390\/ijms161023905","journal-title":"Int J Mol Sci"},{"key":"1441_CR25","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1161\/hc3001.093437","volume":"104","author":"SC Siu","year":"2001","unstructured":"Siu SC, Sermer M, Colman JM et al (2001) Clinical investigation and reports prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation 104:515\u2013521. \n                    https:\/\/doi.org\/10.1161\/hc3001.093437","journal-title":"Circulation"},{"key":"1441_CR26","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1016\/j.jacc.2018.03.492","volume":"71","author":"U Elkayam","year":"2018","unstructured":"Elkayam U (2018) How to predict pregnancy risk in an individual woman with heart disease. J Am Coll Cardiol 71:2431\u20132433. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2018.03.492","journal-title":"J Am Coll Cardiol"},{"key":"1441_CR27","doi-asserted-by":"publisher","unstructured":"Cornelia R. Graves SFD (2018) Cardiovascular complications in pregnancy. Circulation 1213\u20131215. \n                    https:\/\/doi.org\/10.1016\/j.ajog.2015.05.008.3","DOI":"10.1016\/j.ajog.2015.05.008.3"},{"key":"1441_CR28","doi-asserted-by":"publisher","first-page":"R2029","DOI":"10.1152\/ajpregu.2001.281.6.R2029","volume":"281","author":"M Iemitsu","year":"2001","unstructured":"Iemitsu M, Miyauchi T, Maeda S et al (2001) Physiological and pathological cardiac hypertrophy induce different molecular phenotypes in the rat. Am J Physiol Integr Comp Physiol 281:R2029\u2013R2036. \n                    https:\/\/doi.org\/10.1152\/ajpregu.2001.281.6.R2029","journal-title":"Am J Physiol Integr Comp Physiol"},{"key":"1441_CR29","unstructured":"Tsang W, Lang RM (2013) Peripartum cardiomyopathy: Etiology, clinical manifestations, and diagnosis. Wolters kluwer. \n                    https:\/\/www.uptodate.com\/contents\/peripartum-cardiomyopathy-etiology-clinical-manifestations-and-diagnosis\/print\n                    \n                  . Accessed 9 Feb 2019"},{"key":"1441_CR30","doi-asserted-by":"publisher","first-page":"60","DOI":"10.5830\/CVJA-2016-008","volume":"27","author":"P Soma-Pillay","year":"2016","unstructured":"Soma-Pillay P, Seabe J, Sliwa K (2016) The importance of cardiovascular pathology contributing to maternal death: confidential enquiry into maternal deaths in South Africa, 2011\u20132013. Cardiovasc J Afr 27:60\u201365. \n                    https:\/\/doi.org\/10.5830\/CVJA-2016-008","journal-title":"Cardiovasc J Afr"},{"key":"1441_CR31","unstructured":"Moodley J, Fawcus S, Pattinson R (2015) Saving mothers 2011\u20132013: sixth report on confidential enquiries into maternal deaths in South Africa Short report"},{"key":"1441_CR32","first-page":"164","volume":"4","author":"A Rohilla","year":"2012","unstructured":"Rohilla A, Kumar P, Rohilla S, Kushnoor A (2012) Cardiac hypertrophy: a review on pathogenesis and treatment. Int J Pharm Sci Drug Res 4:164\u2013167","journal-title":"Int J Pharm Sci Drug Res"},{"key":"1441_CR33","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.yjmcc.2014.09.004","volume":"76","author":"AM Yeves","year":"2014","unstructured":"Yeves AM, Villa-Abrille MC, P\u00e9rez NG et al (2014) Physiological cardiac hypertrophy: critical role of AKT in the prevention of NHE-1 hyperactivity. J Mol Cell Cardiol 76:186\u2013195. \n                    https:\/\/doi.org\/10.1016\/j.yjmcc.2014.09.004","journal-title":"J Mol Cell Cardiol"},{"key":"1441_CR34","doi-asserted-by":"publisher","first-page":"211","DOI":"10.14310\/horm.2002.1582","volume":"14","author":"E Kintiraki","year":"2015","unstructured":"Kintiraki E, Papakatsika S, Kotronis G et al (2015) Pregnancy-induced hypertension. Horm 14:211\u2013223. \n                    https:\/\/doi.org\/10.14310\/horm.2002.1582","journal-title":"Horm"},{"key":"1441_CR35","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1111\/1471-0528.13117","volume":"122","author":"S Al-Nasiry","year":"2015","unstructured":"Al-Nasiry S, Ghossein-Doha C, Polman SEJ et al (2015) Metabolic syndrome after pregnancies complicated by pre-eclampsia or small-for-gestational-age: a retrospective cohort. BJOG An Int J Obstet Gynaecol 122:1818\u20131823. \n                    https:\/\/doi.org\/10.1111\/1471-0528.13117","journal-title":"BJOG An Int J Obstet Gynaecol"},{"key":"1441_CR36","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1258\/om.2010.100054","volume":"4","author":"L Blauwet","year":"2011","unstructured":"Blauwet L, Sliwa K (2011) Peripartum cardiomyopathy. Obstet Med 4:44\u201352. \n                    https:\/\/doi.org\/10.1258\/om.2010.100054","journal-title":"Obstet Med"},{"issue":"5","key":"1441_CR37","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s11897-018-0404-x","volume":"15","author":"F Azibani","year":"2018","unstructured":"Azibani F, Sliwa K (2018) Peripartum cardiomyopathy: an update. Curr Heart Fail Rep 15(5):297\u2013306. \n                    https:\/\/doi.org\/10.1007\/s11897-018-0404-x","journal-title":"Curr Heart Fail Rep"},{"key":"1441_CR38","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/nrcardio.2014.37","volume":"11","author":"D Hilfiker-Kleiner","year":"2014","unstructured":"Hilfiker-Kleiner D, Sliwa K (2014) Pathophysiology and epidemiology of peripartum cardiomyopathy. Nat Rev Cardiol 11:364\u2013370. \n                    https:\/\/doi.org\/10.1038\/nrcardio.2014.37","journal-title":"Nat Rev Cardiol"},{"key":"1441_CR39","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nature11040","volume":"485","author":"IS Patten","year":"2012","unstructured":"Patten IS, Rana S, Shahul S et al (2012) Cardiac angiogenic imbalance leads to peripartum cardiomyopathy. Nature 485:333\u2013338. \n                    https:\/\/doi.org\/10.1038\/nature11040","journal-title":"Nature"},{"key":"1441_CR40","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.cell.2006.12.036","volume":"128","author":"D Hilfiker-Kleiner","year":"2007","unstructured":"Hilfiker-Kleiner D, Kaminski K, Podewski E et al (2007) A cathepsin D-Cleaved 16\u00a0kDa form of prolactin mediates postpartum cardiomyopathy. Cell 128:589\u2013600. \n                    https:\/\/doi.org\/10.1016\/j.cell.2006.12.036","journal-title":"Cell"},{"key":"1441_CR41","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nature11040","volume":"485","author":"IS Patten","year":"2012","unstructured":"Patten IS, Rana S, Shahul S et al (2012) Sup-cardiac angiogenic imbalance leads to peripartum cardiomyopathy. Nature 485:333\u2013338. \n                    https:\/\/doi.org\/10.1038\/nature11040","journal-title":"Nature"},{"key":"1441_CR42","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1172\/JCI64365","volume":"123","author":"J Halkein","year":"2013","unstructured":"Halkein J, Tabruyn SP, Ricke-Hoch M et al (2013) MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy. J Clin Invest 123:2143\u20132154. \n                    https:\/\/doi.org\/10.1172\/JCI64365","journal-title":"J Clin Invest"},{"key":"1441_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tcm.2018.07.012","volume":"0","author":"K Stergiopoulos","year":"2018","unstructured":"Stergiopoulos K, Lima FV (2018) Peripartum cardiomyopathy-diagnosis, management, and long term implications. Trends Cardiovasc Med 0:1\u201310. \n                    https:\/\/doi.org\/10.1016\/j.tcm.2018.07.012","journal-title":"Trends Cardiovasc Med"},{"key":"1441_CR44","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1093\/eurjhf\/hfq120","volume":"12","author":"K Sliwa","year":"2010","unstructured":"Sliwa K, Hilfiker-Kleiner D, Petrie MC et al (2010) Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail 12:767\u2013778. \n                    https:\/\/doi.org\/10.1093\/eurjhf\/hfq120","journal-title":"Eur J Heart Fail"},{"key":"1441_CR45","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-018-1355-7","author":"A Haghikia","year":"2018","unstructured":"Haghikia A, Schwab J, Vogel J et al (2018) Bromocriptine treatment in patients with peripartum cardiomyopathy and right ventricular dysfunction. Clin Res Cardiol. \n                    https:\/\/doi.org\/10.1007\/s00392-018-1355-7","journal-title":"Clin Res Cardiol"},{"key":"1441_CR46","doi-asserted-by":"publisher","first-page":"1.1","DOI":"10.1146\/annurev-med-041316","volume":"69","author":"Z Arany","year":"2018","unstructured":"Arany Z (2018) Understanding peripartum cardiomyopathy. Annu Rev Med 69:1.1\u20131.12. \n                    https:\/\/doi.org\/10.1146\/annurev-med-041316","journal-title":"Annu Rev Med"},{"key":"1441_CR47","doi-asserted-by":"publisher","first-page":"3147","DOI":"10.1093\/eurheartj\/ehr218","volume":"32","author":"V Regitz-Zagrosek","year":"2018","unstructured":"Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C et al (2018) 2018 ESC Guidelines on the management of cardiovascular diseases during pregnancy. Eur Heart J 32:3147\u20133197. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/ehr218","journal-title":"Eur Heart J"},{"key":"1441_CR48","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1002\/ejhf.586","volume":"18","author":"J Bauersachs","year":"2016","unstructured":"Bauersachs J, Arrigo M, Hilfiker-Kleiner D et al (2016) Current management of patients with severe acute peripartum cardiomyopathy: practical guidance from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy. Eur J Heart Fail 18:1096\u20131105. \n                    https:\/\/doi.org\/10.1002\/ejhf.586","journal-title":"Eur J Heart Fail"},{"key":"1441_CR49","doi-asserted-by":"publisher","DOI":"10.1177\/1074248418783745","author":"K Kido","year":"2018","unstructured":"Kido K, Guglin M (2018) Anticoagulation therapy in specific cardiomyopathies: isolated left ventricular non-compaction and peripartum cardiomyopathy. J Cardiovasc Pharmacol Therap. \n                    https:\/\/doi.org\/10.1177\/1074248418783745","journal-title":"J Cardiovasc Pharmacol Therap"},{"key":"1441_CR50","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-015-0893-5","author":"M Hoeltzenbein","year":"2015","unstructured":"Hoeltzenbein M, Beck E, Meixner K et al (2015) Pregnancy outcome after exposure to the novel oral anticoagulant rivaroxaban in women at suspected risk for thromboembolic events: a case series from the German Embryotox Pharmacovigilance Centre. Clin Res Cardiol. \n                    https:\/\/doi.org\/10.1007\/s00392-015-0893-5","journal-title":"Clin Res Cardiol"},{"key":"1441_CR51","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-017-1090-5","author":"D Duncker","year":"2017","unstructured":"Duncker D, Westenfeld R, Konrad T et al (2017) Risk for life-threatening arrhythmia in newly diagnosed peripartum cardiomyopathy with low ejection fraction: a German multi-centre analysis. Clin Res Cardiol. \n                    https:\/\/doi.org\/10.1007\/s00392-017-1090-5","journal-title":"Clin Res Cardiol"},{"key":"1441_CR52","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.jacc.2013.01.080","volume":"62","author":"S Brewster","year":"2013","unstructured":"Brewster S, Zinman B, Retnakaran R, Floras JS (2013) Cardiometabolic consequences of gestational dysglycemia. J Am Coll Cardiol 62:677\u2013684. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2013.01.080","journal-title":"J Am Coll Cardiol"},{"key":"1441_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fendo.2018.00002","volume":"9","author":"S Rosa De","year":"2018","unstructured":"De Rosa S, Arcidiacono B, Chiefari E et al (2018) Type 2 diabetes mellitus and cardiovascular disease: Genetic and epigenetic links. Front Endocrinol (Lausanne) 9:1\u201313. \n                    https:\/\/doi.org\/10.3389\/fendo.2018.00002","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1441_CR54","doi-asserted-by":"publisher","first-page":"355","DOI":"10.4093\/dmj.2018.0041","volume":"42","author":"CH Lee","year":"2018","unstructured":"Lee CH, Lee S, Park S (2018) Diabetes and subclinical coronary atherosclerosis. Diabetes Metab J 42:355\u2013363","journal-title":"Diabetes Metab J"},{"key":"1441_CR55","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1161\/CIRCRESAHA.116.307547","volume":"118","author":"M Garcia","year":"2016","unstructured":"Garcia M, Mulvagh SL, Merz CNB et al (2016) Cardiovascular disease in women: clinical perspectives. Circ Res 118:1273\u20131293. \n                    https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.307547","journal-title":"Circ Res"},{"key":"1441_CR56","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.2337\/dc14-0087","volume":"37","author":"S Kew","year":"2014","unstructured":"Kew S, Ye C, Hanley AJ et al (2014) Cardiometabolic implications of postpartum weight changes in the first year after delivery. Diabetes Care 37:1998\u20132006. \n                    https:\/\/doi.org\/10.2337\/dc14-0087","journal-title":"Diabetes Care"},{"key":"1441_CR57","first-page":"1","volume-title":"Basic and clinical endocrinology. Endotext [Internet]","author":"R Taylor","year":"2015","unstructured":"Taylor R, Burney SH RO (2015) Endocrinology of pregnancy. In: De Groot LJ, Chrousos G, Dungan K et al (eds) Basic and clinical endocrinology. Endotext [Internet]. MDText.com, South Dartmouth, pp\u00a01\u201367"},{"key":"1441_CR58","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.mce.2011.10.014","volume":"349","author":"JZ Chen","year":"2012","unstructured":"Chen JZ, Sheehan PM, Brennecke SP, Keogh RJ (2012) Molecular and cellular endocrinology vessel remodelling, pregnancy hormones and extravillous trophoblast function. Mol Cell Endocrinol 349:138\u2013144. \n                    https:\/\/doi.org\/10.1016\/j.mce.2011.10.014","journal-title":"Mol Cell Endocrinol"},{"key":"1441_CR59","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/978-3-319-62817-2_6","volume":"1015","author":"G Gonza\u00b4lez-Mariscal","year":"2017","unstructured":"Gonza\u00b4lez-Mariscal G, Melo AI (2017) Bidirectional effects of mother-young contact on the maternal and neonatal brains parental behavior. Adv Exp Med Biol 1015:97\u2013116. \n                    https:\/\/doi.org\/10.1007\/978-3-319-62817-2_6","journal-title":"Adv Exp Med Biol"},{"key":"1441_CR60","doi-asserted-by":"publisher","first-page":"179","DOI":"10.4103\/0300-1652.107549","volume":"53","author":"N Magon","year":"2012","unstructured":"Magon N, Kumar P (2012) Hormones in pregnancy. Niger Med J 53:179. \n                    https:\/\/doi.org\/10.4103\/0300-1652.107549","journal-title":"Niger Med J"},{"key":"1441_CR61","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0079-6123(01)33012-1","volume":"133","author":"DR Grattan","year":"2001","unstructured":"Grattan DR (2001) The actions of prolactin in the brain during pregnancy and lactation. Prog Brain Res 133:153\u2013171. \n                    https:\/\/doi.org\/10.1016\/S0079-6123(01)33012-1","journal-title":"Prog Brain Res"},{"key":"1441_CR62","unstructured":"Gale T (2006) Gale encyclopaedia of nursing and allied health. \n                    https:\/\/www.encyclopedia.com\/medicine\/encyclopedias-almanacs-transcripts-and-maps\/lactation-0\n                    \n                  . Accessed 9 Feb 2019"},{"key":"1441_CR63","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jsbmb.2017.12.015","volume":"178","author":"I Camacho-Arroyo","year":"2018","unstructured":"Camacho-Arroyo I, Gonz\u00e1lez-Arenas A, Jim\u00e9nez-Arellano C et al (2018) Sex hormone levels and expression of their receptors in lactating and lactating pregnant rats. J Steroid Biochem Mol Biol 178:213\u2013220. \n                    https:\/\/doi.org\/10.1016\/j.jsbmb.2017.12.015","journal-title":"J Steroid Biochem Mol Biol"},{"key":"1441_CR64","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S0960-0760(03)00360-1","volume":"86","author":"ER Simpson","year":"2003","unstructured":"Simpson ER (2003) Sources of estrogen and their importance. J Steroid Biochem Mol Biol 86:225\u2013230. \n                    https:\/\/doi.org\/10.1016\/S0960-0760(03)00360-1","journal-title":"J Steroid Biochem Mol Biol"},{"key":"1441_CR65","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.molmed.2012.12.007.Estrogen","volume":"19","author":"J Cui","year":"2011","unstructured":"Cui J, Shen Y, Li R (2011) Estrogen synthesis and signaling pathways during ageing: from periphery to brain. Trends Mol Med 19:976\u2013997. \n                    https:\/\/doi.org\/10.1016\/j.molmed.2012.12.007.Estrogen","journal-title":"Trends Mol Med"},{"key":"1441_CR66","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/S0960-0760(01)00184-4","volume":"346","author":"CJ Gruber","year":"2002","unstructured":"Gruber CJ, Tschugguel W, Schneeberger C, Huber J (2002) Production and action of estrogens. N Engl J Med 346:340\u2013352. \n                    https:\/\/doi.org\/10.1016\/S0960-0760(01)00184-4","journal-title":"N Engl J Med"},{"key":"1441_CR67","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1152\/ajpheart.00217.2016","volume":"70112","author":"AC Boese","year":"2017","unstructured":"Boese AC, Kim SC, Yin K et al (2017) Sex differences in vascular physiology and pathophysiology: estrogen and androgen signaling in health and disease. Am J Physiol Hear Circ Physiol 70112:524\u2013545. \n                    https:\/\/doi.org\/10.1152\/ajpheart.00217.2016","journal-title":"Am J Physiol Hear Circ Physiol"},{"key":"1441_CR68","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.mce.2014.02.001","volume":"389","author":"KH Kim","year":"2014","unstructured":"Kim KH, Young BD, Bender JR (2014) Endothelial estrogen receptor isoforms and cardiovascular disease. Mol Cell Endocrinol 389:65\u201370. \n                    https:\/\/doi.org\/10.1016\/j.mce.2014.02.001","journal-title":"Mol Cell Endocrinol"},{"key":"1441_CR69","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/615917","author":"R Monteiro","year":"2014","unstructured":"Monteiro R, Teixeira D, Calhau C (2014) Estrogen signaling in metabolic inflammation. Mediators Inflamm. \n                    https:\/\/doi.org\/10.1155\/2014\/615917","journal-title":"Mediators Inflamm"},{"key":"1441_CR70","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.numecd.2011.11.002","volume":"28","author":"C-M Liou","year":"2010","unstructured":"Liou C-M, Yang A-L, Kuo C-H et al (2010) Effects of 17 Beta-estradiol on cardiac apoptosis in overiectomized rats. Cell Biochem Funct 28:521\u2013528. \n                    https:\/\/doi.org\/10.1016\/j.numecd.2011.11.002","journal-title":"Cell Biochem Funct"},{"key":"1441_CR71","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1002\/jcb.21936.Estrogenic","volume":"105","author":"CM Klinge","year":"2009","unstructured":"Klinge CM (2009) Estrogenic control of mitochondrial function and biogenesis. Cell 105:1342\u20131351. \n                    https:\/\/doi.org\/10.1002\/jcb.21936.Estrogenic","journal-title":"Cell"},{"key":"1441_CR72","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1161\/CIRCRESAHA.110.236687","volume":"109","author":"E Murphy","year":"2011","unstructured":"Murphy E (2011) Estrogen signaling and cardiovascular disease. Circ Res 109:687\u2013696. \n                    https:\/\/doi.org\/10.1161\/CIRCRESAHA.110.236687","journal-title":"Circ Res"},{"key":"1441_CR73","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13293-017-0152-8","volume":"8","author":"A Iorga","year":"2017","unstructured":"Iorga A, Cunningham CM, Moazeni S et al (2017) The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy. Biol Sex Differ 8:33. \n                    https:\/\/doi.org\/10.1186\/s13293-017-0152-8","journal-title":"Biol Sex Differ"},{"key":"1441_CR74","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s00424-013-1247-7","volume":"465","author":"PA Arias-Loza","year":"2013","unstructured":"Arias-Loza PA, Muehlfelder M, Pelzer T (2013) Estrogen and estrogen receptors in cardiovascular oxidative stress. Pflugers Arch Eur J Physiol 465:739\u2013746. \n                    https:\/\/doi.org\/10.1007\/s00424-013-1247-7","journal-title":"Pflugers Arch Eur J Physiol"},{"key":"1441_CR75","doi-asserted-by":"publisher","first-page":"H3713","DOI":"10.1152\/ajpheart.00736.2007","volume":"293","author":"PA Scott","year":"2007","unstructured":"Scott PA, Tremblay A, Brochu M, St-Louis J (2007) Vasorelaxant action of 17-estradiol in rat uterine arteries: role of nitric oxide synthases and estrogen receptors. Am J Physiol Hear Circ Physiol 293:H3713\u2013H3719","journal-title":"Am J Physiol Hear Circ Physiol"},{"key":"1441_CR76","doi-asserted-by":"publisher","first-page":"12542","DOI":"10.1073\/pnas.0901647106","volume":"106","author":"A Das","year":"2009","unstructured":"Das A, Mantena SR, Kannan A et al (2009) De novo synthesis of estrogen in pregnant uterus is critical for stromal decidualization and angiogenesis. Proc Natl Acad Sci USA 106:12542\u201312547. \n                    https:\/\/doi.org\/10.1073\/pnas.0901647106","journal-title":"Proc Natl Acad Sci USA"},{"key":"1441_CR77","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.cjca.2013.08.006","volume":"30","author":"S Chakrabarti","year":"2014","unstructured":"Chakrabarti S, Morton JS, Davidge ST (2014) Mechanisms of estrogen effects on the endothelium: an overview. Can J Cardiol 30:705\u2013712. \n                    https:\/\/doi.org\/10.1016\/j.cjca.2013.08.006","journal-title":"Can J Cardiol"},{"key":"1441_CR78","doi-asserted-by":"publisher","first-page":"110039","DOI":"10.18632\/oncotarget.22546","volume":"8","author":"C-H Lee","year":"2017","unstructured":"Lee C-H, Su S-C, Chiang C-F et al (2017) Estrogen modulates vascular smooth muscle cell function through downregulation of SIRT1. Oncotarget 8:110039\u2013110051. \n                    https:\/\/doi.org\/10.18632\/oncotarget.22546","journal-title":"Oncotarget"},{"key":"1441_CR79","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1161\/ATVBAHA.110.213637","volume":"30","author":"J Favre","year":"2010","unstructured":"Favre J, Gao J, Henry J-P et al (2010) Endothelial estrogen receptor {alpha} plays an essential role in the coronary and myocardial protective effects of estradiol in ischemia\/reperfusion. Arterioscler Thromb Vasc Biol 30:2562\u20132567. \n                    https:\/\/doi.org\/10.1161\/ATVBAHA.110.213637","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1441_CR80","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.exger.2017.07.016","volume":"97","author":"JC Castardo-De-Paula","year":"2017","unstructured":"Castardo-De-Paula JC, De Campos BH, Amorim EDT et al (2017) Cardiovascular risk and the effect of nitric oxide synthase inhibition in female rats: the role of estrogen. Exp Gerontol 97:38\u201348. \n                    https:\/\/doi.org\/10.1016\/j.exger.2017.07.016","journal-title":"Exp Gerontol"},{"key":"1441_CR81","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1161\/01.RES.0000082334.17947.11","volume":"93","author":"K Strehlow","year":"2003","unstructured":"Strehlow K, Rotter S, Wassmann S et al (2003) Modulation of antioxidant enzyme expression and function by estrogen. Circ Res 93:170\u2013177. \n                    https:\/\/doi.org\/10.1161\/01.RES.0000082334.17947.11","journal-title":"Circ Res"},{"key":"1441_CR82","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2174\/157488712799363253","volume":"7","author":"M Reslan","year":"2012","unstructured":"Reslan M, Khalil OAR (2012) Vascular effects of estrogenic menopausal hormone therapy. Rev Recent Clin Trials 7:47\u201370. \n                    https:\/\/doi.org\/10.2174\/157488712799363253","journal-title":"Rev Recent Clin Trials"},{"key":"1441_CR83","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1183\/09031936.00044112","volume":"41","author":"P Yuan","year":"2013","unstructured":"Yuan P, Wu WH, Gao L et al (2013) Oestradiol ameliorates monocrotaline pulmonary hypertension via NO, prostacyclin and endothelin-1 pathways. Eur Respir J 41:1116\u20131125. \n                    https:\/\/doi.org\/10.1183\/09031936.00044112","journal-title":"Eur Respir J"},{"key":"1441_CR84","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1161\/hc3601.095577","volume":"104","author":"M Eickels","year":"2001","unstructured":"Eickels M, Van Groh\u00e9 C, Cleutjens JPM et al (2001) 17 B-estradiol attenuates the development of pressure overload hypertrophy. Circulation 104:1419\u20131423","journal-title":"Circulation"},{"key":"1441_CR85","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1161\/01.RES.88.1.88","volume":"88","author":"OF Bueno","year":"2001","unstructured":"Bueno OF, De Windt LJ, Lim HW et al (2001) The dual-specificity phosphatase MKP-1 limits the cardiac hypertrophic response in vitro and in vivo. Circ Res 88:88\u201396. \n                    https:\/\/doi.org\/10.1161\/01.RES.88.1.88","journal-title":"Circ Res"},{"key":"1441_CR86","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.jacc.2011.03.042","volume":"58","author":"CSP Lam","year":"2011","unstructured":"Lam CSP, Cheng S, Choong K et al (2011) Influence of sex and hormone status on circulating natriuretic peptides. J Am Coll Cardiol 58:618\u2013626. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2011.03.042","journal-title":"J Am Coll Cardiol"},{"key":"1441_CR87","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.cogdev.2010.08.003.Personal","volume":"104","author":"C Donaldson","year":"2009","unstructured":"Donaldson C, Eder S, Baker C et al (2009) Estrogen attenuates left ventricular and cardiomyocyte hypertrophy by an estrogen receptor-dependent pathway that increases calcineurin degradation. Circ Res 104:265\u2013275. \n                    https:\/\/doi.org\/10.1016\/j.cogdev.2010.08.003.Personal","journal-title":"Circ Res"},{"key":"1441_CR88","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1161\/HYPERTENSIONAHA.111.00276","volume":"61","author":"D G\u00fcrgen","year":"2013","unstructured":"G\u00fcrgen D, Kusch A, Klewitz R et al (2013) Sex-specific mTOR signaling determines sexual dimorphism in myocardial adaptation in normotensive DOCA-salt model. Hypertension 61:730\u2013736. \n                    https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.111.00276","journal-title":"Hypertension"},{"key":"1441_CR89","doi-asserted-by":"publisher","first-page":"3805","DOI":"10.1091\/mbc.E13-08-0444","volume":"24","author":"A Pedram","year":"2013","unstructured":"Pedram A, Razandi M, Narayanan R et al (2013) Estrogen regulates histone deacetylases to prevent cardiac hypertrophy. Mol Biol Cell 24:3805\u20133818. \n                    https:\/\/doi.org\/10.1091\/mbc.E13-08-0444","journal-title":"Mol Biol Cell"},{"key":"1441_CR90","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.yjmcc.2008.11.018","volume":"46","author":"A Kili\u0107","year":"2009","unstructured":"Kili\u0107 A, Javadov S, Karmazyn M (2009) Estrogen exerts concentration-dependent pro-and anti-hypertrophic effects on adult cultured ventricular myocytes. Role of NHE-1 in estrogen-induced hypertrophy. J Mol Cell Cardiol 46:360\u2013369. \n                    https:\/\/doi.org\/10.1016\/j.yjmcc.2008.11.018","journal-title":"J Mol Cell Cardiol"},{"key":"1441_CR91","doi-asserted-by":"publisher","first-page":"892","DOI":"10.3390\/ijms18040892","volume":"18","author":"K-H Lin","year":"2017","unstructured":"Lin K-H, Kuo W-W, Shibu M et al (2017) E2\/ER \u03b2 enhances calcineurin protein degradation and PI3K\/Akt\/MDM2 signal transduction to inhibit ISO-induced myocardial cell apoptosis. Int J Mol Sci 18:892. \n                    https:\/\/doi.org\/10.3390\/ijms18040892","journal-title":"Int J Mol Sci"},{"key":"1441_CR92","doi-asserted-by":"publisher","first-page":"H497","DOI":"10.1152\/ajpheart.00336.2009","volume":"298","author":"JD Gardner","year":"2010","unstructured":"Gardner JD, Murray DB, Voloshenyuk TG et al (2010) Estrogen attenuates chronic volume overload induced structural and functional remodeling in male rat hearts. AJP Hear Circ Physiol 298:H497\u2013H504. \n                    https:\/\/doi.org\/10.1152\/ajpheart.00336.2009","journal-title":"AJP Hear Circ Physiol"},{"key":"1441_CR93","doi-asserted-by":"publisher","first-page":"3197","DOI":"10.1161\/CIRCULATIONAHA.106.657981","volume":"115","author":"M Satoh","year":"2007","unstructured":"Satoh M, Matter CM, Ogita H et al (2007) Inhibition of apoptosis-regulated signaling kinase-1 and prevention of congestive heart failure by estrogen. Circulation 115:3197\u20133204. \n                    https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.657981","journal-title":"Circulation"},{"key":"1441_CR94","doi-asserted-by":"publisher","first-page":"R1597","DOI":"10.1152\/ajpregu.00825.2009","volume":"298","author":"D Fliegner","year":"2010","unstructured":"Fliegner D, Schubert C, Penkalla A et al (2010) Female sex and estrogen receptor- attenuate cardiac remodeling and apoptosis in pressure overload. AJP Regul Integr Comp Physiol 298:R1597\u2013R1606. \n                    https:\/\/doi.org\/10.1152\/ajpregu.00825.2009","journal-title":"AJP Regul Integr Comp Physiol"},{"key":"1441_CR95","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.cjca.2015.10.021","volume":"32","author":"T Luo","year":"2016","unstructured":"Luo T, Kim JK (2016) The role of estrogen and estrogen receptors on cardiomyocytes: an overview. Can J Cardiol 32:1017\u20131025. \n                    https:\/\/doi.org\/10.1016\/j.cjca.2015.10.021","journal-title":"Can J Cardiol"},{"key":"1441_CR96","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.tem.2005.01.004","volume":"16","author":"D Kalaitzidis","year":"2005","unstructured":"Kalaitzidis D, Gilmore TD (2005) Transcription factor cross-talk: the estrogen receptor and NF-\u03baB. Trends Endocrinol Metab 16:46\u201352. \n                    https:\/\/doi.org\/10.1016\/j.tem.2005.01.004","journal-title":"Trends Endocrinol Metab"},{"key":"1441_CR97","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1161\/01.RES.0000144126.57786.89","volume":"95","author":"RD Patten","year":"2004","unstructured":"Patten RD, Pourati I, Aronovitz MJ et al (2004) 17\u03b2-estradiol reduces cardiomyocyte apoptosis in vivo and in vitro via activation of phospho-inositide-3 kinase\/Akt signaling. Circ Res 95:692\u2013699. \n                    https:\/\/doi.org\/10.1161\/01.RES.0000144126.57786.89","journal-title":"Circ Res"},{"key":"1441_CR98","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/j.1743-6109.2008.01122.x.Endothelial","volume":"6","author":"M Satoh","year":"2009","unstructured":"Satoh M, Matter CM, Ogita H, Takeshita K, Wang C-Y, Dorn GW, Liao JK (2009) Inhibition of apoptosis-regulated signaling kinase-1 and prevention of congestive heart failure by estrogen. Circulation 6:247\u2013253. \n                    https:\/\/doi.org\/10.1111\/j.1743-6109.2008.01122.x.Endothelial","journal-title":"Circulation"},{"key":"1441_CR99","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/cvr\/cvq265","volume":"89","author":"H Liu","year":"2011","unstructured":"Liu H, Pedram A, Kim JK (2011) Oestrogen prevents cardiomyocyte apoptosis by suppressing p38\u03b1-mediated activation of p53 and by down-regulating p53 inhibition on p38\u03b2. Cardiovasc Res 89:119\u2013128. \n                    https:\/\/doi.org\/10.1093\/cvr\/cvq265","journal-title":"Cardiovasc Res"},{"key":"1441_CR100","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1161\/01.RES.0000021114.92282.FA","volume":"90","author":"G Pare","year":"2002","unstructured":"Pare G, Krust A, Karas RH et al (2002) Estrogen receptor-\u03b1 mediates the protective effects of estrogen against vascular injury. Circ Res 90:1087\u20131092. \n                    https:\/\/doi.org\/10.1161\/01.RES.0000021114.92282.FA","journal-title":"Circ Res"},{"key":"1441_CR101","doi-asserted-by":"publisher","first-page":"18178","DOI":"10.1074\/jbc.M117.790121","volume":"292","author":"F Fortini","year":"2017","unstructured":"Fortini F, Dalla Sega FV, Caliceti C et al (2017) Estrogen receptor \u03b2-dependent Notch1 activation protects vascular endothelium against tumor necrosis factor \u03b1 (TNF\u03b1)-induced apoptosis. J Biol Chem 292:18178\u201318191. \n                    https:\/\/doi.org\/10.1074\/jbc.M117.790121","journal-title":"J Biol Chem"},{"key":"1441_CR102","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1210\/en.2016-1677","volume":"158","author":"D Clegg","year":"2017","unstructured":"Clegg D, Hevener AL, Moreau KL et al (2017) Sex hormones and cardiometabolic health: role of estrogen and estrogen receptors. Metabolism 158:1095\u20131105. \n                    https:\/\/doi.org\/10.1210\/en.2016-1677","journal-title":"Metabolism"},{"key":"1441_CR103","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0014-5793(97)01179-4","volume":"416","author":"C Groh\u00e9","year":"1997","unstructured":"Groh\u00e9 C, Kahlert S, L\u00f6bbert K et al (1997) Cardiac myocytes and fibroblasts contain functional estrogen receptors. FEBS Lett 416:107\u2013112. \n                    https:\/\/doi.org\/10.1016\/S0014-5793(97)01179-4","journal-title":"FEBS Lett"},{"key":"1441_CR104","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.physbeh.2009.08.013.Estrogen","volume":"99","author":"V Elwood","year":"2010","unstructured":"Elwood V, Jensen. Herbert I, Jacobson. Alicia A, Walf, Cheryl AF (2010) Estrogen action: a historic perspective on the implications of considering alternative approaches. Physiol Behav 99:151\u2013162. \n                    https:\/\/doi.org\/10.1016\/j.physbeh.2009.08.013.Estrogen","journal-title":"Physiol Behav"},{"key":"1441_CR105","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1621\/nrs.04013","volume":"4","author":"JK Kim","year":"2006","unstructured":"Kim JK, Levin ER (2006) Estrogen signaling in the cardiovascular system. Nucl Recept Signal 4:1\u20135. \n                    https:\/\/doi.org\/10.1621\/nrs.04013","journal-title":"Nucl Recept Signal"},{"key":"1441_CR106","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jsbmb.2016.05.022","volume":"165","author":"E Iwabuchi","year":"2017","unstructured":"Iwabuchi E, Miki Y, Ono K et al (2017) In situ detection of estrogen receptor dimers in breast carcinoma cells in archival materials using proximity ligation assay (PLA). J Steroid Biochem Mol Biol 165:159\u2013169. \n                    https:\/\/doi.org\/10.1016\/j.jsbmb.2016.05.022","journal-title":"J Steroid Biochem Mol Biol"},{"key":"1441_CR107","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jsbmb.2010.06.012","volume":"122","author":"A Foryst-Ludwig","year":"2010","unstructured":"Foryst-Ludwig A, Kintscher U (2010) Metabolic impact of estrogen signalling through ERalpha and ERbeta. J Steroid Biochem Mol Biol 122:74\u201381. \n                    https:\/\/doi.org\/10.1016\/j.jsbmb.2010.06.012","journal-title":"J Steroid Biochem Mol Biol"},{"key":"1441_CR108","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1126\/science.1106943","volume":"307","author":"CM Ravankar","year":"2005","unstructured":"Ravankar CM, Cimino DF, Sklar LA et al (2005) A transmembrane intercellulare estrogen receptor mediates rapid cell signaling. Science 307:1625\u20131630","journal-title":"Science"},{"key":"1441_CR109","doi-asserted-by":"publisher","first-page":"3236","DOI":"10.1210\/en.2006-1605","volume":"148","author":"E Filardo","year":"2007","unstructured":"Filardo E, Quinn J, Pang Y et al (2007) Activation of the novel estrogen receptor G protein-coupled receptor 30 (GPR30) at the plasma membrane. Endocrinology 148:3236\u20133245. \n                    https:\/\/doi.org\/10.1210\/en.2006-1605","journal-title":"Endocrinology"},{"key":"1441_CR110","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1210\/en.2004-1064","volume":"146","author":"P Thomas","year":"2005","unstructured":"Thomas P, Pang Y, Filardo EJ, Dong J (2005) Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology 146:624\u2013632. \n                    https:\/\/doi.org\/10.1210\/en.2004-1064","journal-title":"Endocrinology"},{"key":"1441_CR111","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.vph.2011.06.003","volume":"55","author":"MR Meyer","year":"2011","unstructured":"Meyer MR, Prossnitz ER, Barton M (2011) The G protein-coupled estrogen receptor GPER\/GPR30 as a regulator of cardiovascular function. Vascul Pharmacol 55:17\u201325. \n                    https:\/\/doi.org\/10.1016\/j.vph.2011.06.003","journal-title":"Vascul Pharmacol"},{"key":"1441_CR112","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1006\/bbrc.1997.7734","volume":"240","author":"Y Takada","year":"1997","unstructured":"Takada Y, Kato C, Kondo S et al (1997) Cloning of cDNAs encoding G protein-coupled receptor expressed in human endothelial cells exposed to fluid shear stress. Biochem Biophys Res Commun 240:737\u2013741. \n                    https:\/\/doi.org\/10.1006\/bbrc.1997.7734","journal-title":"Biochem Biophys Res Commun"},{"key":"1441_CR113","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1507\/endocrj.K09E-332","volume":"57","author":"Y Mizukami","year":"2010","unstructured":"Mizukami Y (2010) In vivo functions of GPR30\/GPER-1, a membrane receptor for estrogen: from discovery to functions in vivo. Endocr J 57:101\u2013107. \n                    https:\/\/doi.org\/10.1507\/endocrj.K09E-332","journal-title":"Endocr J"},{"key":"1441_CR114","first-page":"43","volume":"113","author":"J Tomac","year":"2011","unstructured":"Tomac J, Cekinov\u0107 D, Arapovi\u0107 J (2011) Biology of the corpus luteum. Period Biol 113:43\u201349","journal-title":"Period Biol"},{"key":"1441_CR115","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.placenta.2004.06.012","volume":"26","author":"RC Tuckey","year":"2005","unstructured":"Tuckey RC (2005) Progesterone synthesis by the human placenta. Placenta 26:273\u2013281. \n                    https:\/\/doi.org\/10.1016\/j.placenta.2004.06.012","journal-title":"Placenta"},{"key":"1441_CR116","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1097\/01.CCM.0000063441.41446.23","volume":"31","author":"JF Kuebler","year":"2003","unstructured":"Kuebler JF, Jarrar D, Bland KI et al (2003) Progesterone administration after trauma and hemorrhagic shock improves cardiovascular responses. Crit Care Med 31:1786\u20131793. \n                    https:\/\/doi.org\/10.1097\/01.CCM.0000063441.41446.23","journal-title":"Crit Care Med"},{"key":"1441_CR117","first-page":"377","volume":"1","author":"M Pecins-Thompson","year":"1997","unstructured":"Pecins-Thompson M, Maureen K-W (1997) Effects of progesterone on blood pressure, plasma volume, and responses to hypotension. Am Physiol Soc 1:377\u2013385","journal-title":"Am Physiol Soc"},{"key":"1441_CR118","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1111\/j.1474-9726.2010.00619.x","volume":"9","author":"S Morrissy","year":"2010","unstructured":"Morrissy S, Xu B, Aguilar D et al (2010) Inhibition of apoptosis by progesterone in cardiomyocytes. Aging Cell 9:799\u2013809. \n                    https:\/\/doi.org\/10.1111\/j.1474-9726.2010.00619.x","journal-title":"Aging Cell"},{"key":"1441_CR119","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.steroids.2014.07.010","volume":"89","author":"MB Ram\u00edrez-Rosas","year":"2014","unstructured":"Ram\u00edrez-Rosas MB, Cobos-Puc LE, S\u00e1nchez-L\u00f3pez A et al (2014) Pharmacological characterization of the mechanisms involved in the vasorelaxation induced by progesterone and 17\u03b2-estradiol on isolated canine basilar and internal carotid. Steroids 89:33\u201340. \n                    https:\/\/doi.org\/10.1016\/j.steroids.2014.07.010","journal-title":"Steroids"},{"key":"1441_CR120","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s00424-010-0797-1.Hormonal","volume":"459","author":"VM Miller","year":"2010","unstructured":"Miller VM (2010) Hormonal modulation of endothelial NO production Sue. Pflugers Arch 459:841\u2013851. \n                    https:\/\/doi.org\/10.1007\/s00424-010-0797-1.Hormonal","journal-title":"Pflugers Arch"},{"key":"1441_CR121","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1161\/01.RES.87.5.406","volume":"87","author":"SH Nelson","year":"2000","unstructured":"Nelson SH, Steinsland OS, Wang Y et al (2000) Increased nitric oxide synthase activity and expression in the human uterine artery during pregnancy. Circ Res 87:406\u2013411. \n                    https:\/\/doi.org\/10.1161\/01.RES.87.5.406","journal-title":"Circ Res"},{"key":"1441_CR122","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jmb.2008.10.054.The","volume":"211","author":"L Amaral","year":"2014","unstructured":"Amaral L, Kiprono L, Cornelius D et al (2014) Progesterone supplementation attenuates hypertension and the autoantibody to the angiotensin II type I receptor in response to elevated interleukin-6 during pregnancy. Am J Obs Gynecol 211:22\u201329. \n                    https:\/\/doi.org\/10.1016\/j.jmb.2008.10.054.The","journal-title":"Am J Obs Gynecol"},{"key":"1441_CR123","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3109\/19396360903469307","volume":"56","author":"JA Arroyo","year":"2010","unstructured":"Arroyo JA, Anthony RV, Parker TA, Galan HL (2010) ENOS, NO, and the activation of ERK and AKT signaling at mid-gestation and near-term in an ovine model of intrauterine growth restriction. Syst Biol Reprod Med 56:62\u201373. \n                    https:\/\/doi.org\/10.3109\/19396360903469307","journal-title":"Syst Biol Reprod Med"},{"key":"1441_CR124","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1161\/01.HYP.37.1.142","volume":"37","author":"M Barbagallo","year":"2001","unstructured":"Barbagallo M, Dominguez LJ, Licata G et al (2001) Vascular effects of progesterone: role of cellular calcium regulation. Hypertension 37:142\u2013147. \n                    https:\/\/doi.org\/10.1161\/01.HYP.37.1.142","journal-title":"Hypertension"},{"key":"1441_CR125","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1124\/mol.104.003814","volume":"67","author":"QM Chen","year":"2005","unstructured":"Chen QM, Alexander D, Sun H et al (2005) Corticosteroids inhibit cell death induced by doxorubicin in cardiomyocytes: induction of antiapoptosis, antioxidant, and detoxification genes. Mol Pharmacol 67:1861\u20131873. \n                    https:\/\/doi.org\/10.1124\/mol.104.003814","journal-title":"Mol Pharmacol"},{"key":"1441_CR126","doi-asserted-by":"publisher","first-page":"H46","DOI":"10.1152\/ajpheart.00073.2016","volume":"312","author":"HA Feridooni","year":"2017","unstructured":"Feridooni HA, MacDonald JK, Ghimire A et al (2017) Acute exposure to progesterone attenuates cardiac contraction by modifying myofilament calcium sensitivity in the female mouse heart. Am J Physiol Hear Circ Physiol 312:H46\u2013H59. \n                    https:\/\/doi.org\/10.1152\/ajpheart.00073.2016","journal-title":"Am J Physiol Hear Circ Physiol"},{"key":"1441_CR127","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.genm.2009.09.011","volume":"6","author":"SE Nilsson","year":"2009","unstructured":"Nilsson SE, Fransson E, Brismar K (2009) Relationship between serum progesterone concentrations and cardiovascular disease, diabetes, and mortality in elderly Swedish men and women: an 8-year prospective study. Gend Med 6:433\u2013443. \n                    https:\/\/doi.org\/10.1016\/j.genm.2009.09.011","journal-title":"Gend Med"},{"key":"1441_CR128","doi-asserted-by":"publisher","first-page":"C82","DOI":"10.1152\/ajpcell.00287.2006","volume":"292","author":"PK Mehta","year":"2007","unstructured":"Mehta PK, Griendling KK (2007) Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 292:C82\u2013C97. \n                    https:\/\/doi.org\/10.1152\/ajpcell.00287.2006","journal-title":"Am J Physiol Cell Physiol"},{"key":"1441_CR129","doi-asserted-by":"publisher","first-page":"15108","DOI":"10.1074\/jbc.M116.726737","volume":"291","author":"X Yang","year":"2016","unstructured":"Yang X, Zhang W, Chen Y et al (2016) Activation of peroxisome proliferator-activated receptor \u03b3 (PPAR\u03b3) and CD36 protein expression: the dual pathophysiological roles of progesterone. J Biol Chem 291:15108\u201315118. \n                    https:\/\/doi.org\/10.1074\/jbc.M116.726737","journal-title":"J Biol Chem"},{"key":"1441_CR130","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1126\/science.1249098.Sleep","volume":"344","author":"G Yang","year":"2015","unstructured":"Yang G, Sau C, Lai W et al (2015) Sex hormonal regulation of cardiac ion channels in drug- induced QT syndromes. Pharmacol Ther 344:1173\u20131178. \n                    https:\/\/doi.org\/10.1126\/science.1249098.Sleep","journal-title":"Pharmacol Ther"},{"key":"1441_CR131","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/aogs.12771","volume":"94","author":"S Taraborrelli","year":"2015","unstructured":"Taraborrelli S (2015) Physiology, production and action of progesterone. Physiol Prod action progesterone 94:8\u201316. \n                    https:\/\/doi.org\/10.1111\/aogs.12771","journal-title":"Physiol Prod action progesterone"},{"key":"1441_CR132","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/humupd\/dmn044","volume":"15","author":"B Gellersen","year":"2009","unstructured":"Gellersen B, Fernandes MS, Brosens JJ (2009) Non-genomic progesterone actions in female reproduction. Hum Reprod Update 15:119\u2013138. \n                    https:\/\/doi.org\/10.1093\/humupd\/dmn044","journal-title":"Hum Reprod Update"},{"key":"1441_CR133","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/bcr451","volume":"4","author":"S Soyal","year":"2002","unstructured":"Soyal S, Ismail PM, Li J et al (2002) Progesterone\u2019s role in mammary gland development and tumorigenesis as disclosed by experimental mouse genetics. Breast Cancer Res 4:191\u2013196. \n                    https:\/\/doi.org\/10.1186\/bcr451","journal-title":"Breast Cancer Res"},{"key":"1441_CR134","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.pharmthera.2007.04.008","volume":"115","author":"T Furukawa","year":"2007","unstructured":"Furukawa T, Kurokawa J (2007) Regulation of cardiac ion channels via non-genomic action of sex steroid hormones: implication for the gender difference in cardiac arrhythmias. Pharmacol Ther 115:106\u2013115. \n                    https:\/\/doi.org\/10.1016\/j.pharmthera.2007.04.008","journal-title":"Pharmacol Ther"},{"key":"1441_CR135","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1177\/002215540305100808","volume":"51","author":"BH Welter","year":"2003","unstructured":"Welter BH, Hansen EL, Saner KJ et al (2003) Membrane-bound progesterone receptor expression in human aortic endothelial cells. J Histochem Cytochem 51:1049\u20131055. \n                    https:\/\/doi.org\/10.1177\/002215540305100808","journal-title":"J Histochem Cytochem"},{"key":"1441_CR136","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.steroids.2013.01.003","volume":"78","author":"P Thomas","year":"2013","unstructured":"Thomas P, Pang Y (2013) Protective actions of progesterone in the cardiovascular system: Potential role of membrane progesterone receptors (mPRs) in mediating rapid effects. Steroids 78:583\u2013588. \n                    https:\/\/doi.org\/10.1016\/j.steroids.2013.01.003","journal-title":"Steroids"},{"key":"1441_CR137","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2174\/187152908786786160","volume":"8","author":"T Furukawa","year":"2008","unstructured":"Furukawa T, Kurokawa J (2008) Non-genomic regulation of cardiac ion channels by sex hormones. Cardiovasc Hematol Disord Targets 8:245\u2013251. \n                    https:\/\/doi.org\/10.2174\/187152908786786160","journal-title":"Cardiovasc Hematol Disord Targets"},{"key":"1441_CR138","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1677\/joe.0.1730219","volume":"173","author":"AM Corbacho","year":"2002","unstructured":"Corbacho AM, Mart\u00ednez de la Escalera G, Clapp C (2002) Roles of prolactin and related members of the prolactin\/growth hormone\/placental lactogen family in angiogenesis. J Endocrinol 173:219\u2013238. \n                    https:\/\/doi.org\/10.1677\/joe.0.1730219","journal-title":"J Endocrinol"},{"key":"1441_CR139","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-015-0025-2","author":"M Guclu","year":"2015","unstructured":"Guclu M, Cander S, Kiyici S et al (2015) Serum macroprolactin levels in pregnancy and association with thyroid autoimmunity. BMC Endocr Disord. \n                    https:\/\/doi.org\/10.1186\/s12902-015-0025-2","journal-title":"BMC Endocr Disord"},{"key":"1441_CR140","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1677\/joe.0.1060081","volume":"106","author":"F Pansini","year":"1984","unstructured":"Pansini F, Bergamini CM, Malfaccini M et al (1984) Multiple molecular forms of prolactin during pregnancy in women. J Endocrinol 106:81\u201385","journal-title":"J Endocrinol"},{"key":"1441_CR141","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1152\/physrev.2000.80.4.1523","volume":"80","author":"LA Kanyicska","year":"2000","unstructured":"Kanyicska LA, Lerant A, Freeman ME, Marc E (2000) Prolactin: structure, function, and regulation of secretion. Physiol Rev 80:1523\u20131631","journal-title":"Physiol Rev"},{"key":"1441_CR142","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0133466","volume":"10","author":"NBA Ntusi","year":"2015","unstructured":"Ntusi NBA, Badri M, Gumedze F et al (2015) Pregnancy-associated heart failure: a comparison of clinical presentation and outcome between hypertensive heart failure of pregnancy and idiopathic peripartum cardiomyopathy. PLoS One 10:1\u201313. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0133466","journal-title":"PLoS One"},{"key":"1441_CR143","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.ijcard.2014.11.154","volume":"181","author":"DJY Hsieh","year":"2015","unstructured":"Hsieh DJY, Pai P, Wang SGP et al (2015) Prolactin protects cardiomyocytes against intermittent hypoxia-induced cell damage by the modulation of signaling pathways related to cardiac hypertrophy and proliferation. Int J Cardiol 181:255\u2013266. \n                    https:\/\/doi.org\/10.1016\/j.ijcard.2014.11.154","journal-title":"Int J Cardiol"},{"key":"1441_CR144","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1385\/ENDO:13:1:37","volume":"13","author":"CJ Merkle","year":"2000","unstructured":"Merkle CJ, Schuler LA, Schaeffer RC et al (2000) Structural and functional effects of high prolactin levels on injured endothelial cells: evidence for an endothelial prolactin receptor. Endocrine 13:37\u201346. \n                    https:\/\/doi.org\/10.1385\/ENDO:13:1:37","journal-title":"Endocrine"},{"key":"1441_CR145","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/aps.2014.159","volume":"36","author":"C Gonzalez","year":"2015","unstructured":"Gonzalez C, Rosas-Hernandez H, Jurado-Manzano B et al (2015) The prolactin family hormones regulate vascular tone through NO and prostacyclin production in isolated rat aortic rings. Acta Pharmacol Sin 36:572\u2013586. \n                    https:\/\/doi.org\/10.1038\/aps.2014.159","journal-title":"Acta Pharmacol Sin"},{"key":"1441_CR146","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1161\/HYPERTENSIONAHA.109.132100","volume":"54","author":"GA Georgiopoulos","year":"2009","unstructured":"Georgiopoulos GA, Stamatelopoulos KS, Lambrinoudaki I et al (2009) Prolactin and preclinical atherosclerosis in menopausal women with cardiovascular risk factors. Hypertension 54:98\u2013105. \n                    https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.109.132100","journal-title":"Hypertension"},{"key":"1441_CR147","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1093\/eurheartj\/ehs233","volume":"10","author":"RS Vasan","year":"2014","unstructured":"Vasan RS, Haring R, Friedrich N et al (2014) Positive association of serum prolactin concentrations with all-cause and cardiovascular mortality. Eur Heart J Clin Res 10:1215\u20131221. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/ehs233","journal-title":"Eur Heart J Clin Res"},{"key":"1441_CR148","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.002640","author":"KE Therkelsen","year":"2016","unstructured":"Therkelsen KE, Abraham TM, Pedley A et al (2016) Association between prolactin and incidence of cardiovascular risk. J Am Heart Assoc. \n                    https:\/\/doi.org\/10.1161\/JAHA.115.002640","journal-title":"J Am Heart Assoc"},{"key":"1441_CR149","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fendo.2017.0004","volume":"8","author":"R Nakajima","year":"2017","unstructured":"Nakajima R, Nakamura E, Harigaya T (2017) Vasoinhibin, an N-terminal prolactin fragment, directly inhibits cardiac angiogenesis in three-dimensional heart culture. Front Endocrinol (Lausanne) 8:1\u20136. \n                    https:\/\/doi.org\/10.3389\/fendo.2017.0004","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1441_CR150","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/labinvest.3700662","volume":"87","author":"C Gonz\u00e1lez","year":"2007","unstructured":"Gonz\u00e1lez C, Parra A, Ram\u00edrez-Peredo J et al (2007) Elevated vasoinhibins may contribute to endothelial cell dysfunction and low birth weight in preeclampsia. Lab Investig 87:1009\u20131017. \n                    https:\/\/doi.org\/10.1038\/labinvest.3700662","journal-title":"Lab Investig"},{"key":"1441_CR151","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1159\/000094309","volume":"35","author":"C Clapp","year":"2006","unstructured":"Clapp C, Gonz\u00e1lez C, Macotela Y et al (2006) Vasoinhibins: a family of N-terminal prolactin fragments that inhibit angiogenesis and vascular function. Front Horm Res 35:64\u201373. \n                    https:\/\/doi.org\/10.1159\/000094309","journal-title":"Front Horm Res"},{"key":"1441_CR152","doi-asserted-by":"publisher","first-page":"5714","DOI":"10.1210\/en.2004-0647","volume":"145","author":"C Gonzalez","year":"2004","unstructured":"Gonzalez C, Corbacho AM, Eiserich JP et al (2004) 16K-prolactin inhibits activation of endothelial nitric oxide synthase, intracellular calcium mobilization, and endothelium-dependent vasorelaxation. Endocrinology 145:5714\u20135722. \n                    https:\/\/doi.org\/10.1210\/en.2004-0647","journal-title":"Endocrinology"},{"key":"1441_CR153","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1210\/mend.14.10.0543","volume":"14","author":"JF Martini","year":"2000","unstructured":"Martini JF, Piot C, Humeau LM et al (2000) The antiangiogenic factor 16K PRL induces programmed cell death in endothelial cells by caspase activation. Mol Endocrinol 14:1536\u20131549. \n                    https:\/\/doi.org\/10.1210\/mend.14.10.0543","journal-title":"Mol Endocrinol"},{"key":"1441_CR154","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1210\/me.2003-0132","volume":"17","author":"SP Tabruyn","year":"2003","unstructured":"Tabruyn SP, Sorlet CM, Rentier-Delrue F et al (2003) The antiangiogenic factor 16K human prolactin induces caspase-dependent apoptosis by a mechanism that requires activation of nuclear factor-kappaB. Mol Endocrinol 17:1815\u20131823. \n                    https:\/\/doi.org\/10.1210\/me.2003-0132","journal-title":"Mol Endocrinol"},{"key":"1441_CR155","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jss.2004.09.003","volume":"124","author":"MW Cox","year":"2005","unstructured":"Cox MW, Fu W, Chai H et al (2005) Effects of progesterone and estrogen on endothelial dysfunction in porcine coronary arteries. J Surg Res 124:104\u2013111. \n                    https:\/\/doi.org\/10.1016\/j.jss.2004.09.003","journal-title":"J Surg Res"},{"key":"1441_CR156","doi-asserted-by":"publisher","first-page":"4080","DOI":"10.1210\/en.2006-1577","volume":"148","author":"C Molinari","year":"2007","unstructured":"Molinari C, Grossini E, Mary DASG et al (2007) Prolactin induces regional vasoconstriction through the adrenergic and nitric oxide mechanisms. Endocrinology 148:4080\u20134090. \n                    https:\/\/doi.org\/10.1210\/en.2006-1577","journal-title":"Endocrinology"},{"key":"1441_CR157","first-page":"435","volume":"63","author":"A Ignacak","year":"2012","unstructured":"Ignacak A, Kasztelnik M, Sliwa T et al (2012) Prolactin\u2014not only lactotrophin a \u201cnew\u201d view of the \u201cold\u201d hormone. J Physiol Pharmacol 63:435\u2013443","journal-title":"J Physiol Pharmacol"},{"key":"1441_CR158","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3904\/kjim.2016.360","volume":"32","author":"M-J Kim","year":"2017","unstructured":"Kim M-J, Shin M-S (2017) Practical management of peripartum cardiomyopathy. Korean J Intern Med 32:393\u2013403. \n                    https:\/\/doi.org\/10.3904\/kjim.2016.360","journal-title":"Korean J Intern Med"},{"key":"1441_CR159","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1161\/CIRCULATIONAHA.115.020491","volume":"133","author":"Z Arany","year":"2016","unstructured":"Arany Z, Elkayam U (2016) Peripartum cardiomyopathy. Circulation 133:1397\u20131409. \n                    https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.020491","journal-title":"Circulation"},{"key":"1441_CR160","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1210\/edrv.19.3.0334","volume":"19","author":"C Bole-Feysot","year":"1998","unstructured":"Bole-Feysot C, Goffin V, Edery M et al (1998) Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr Rev 19:225\u2013268. \n                    https:\/\/doi.org\/10.1210\/edrv.19.3.0334","journal-title":"Endocr Rev"},{"key":"1441_CR161","doi-asserted-by":"publisher","first-page":"21184","DOI":"10.1074\/jbc.M113.481119","volume":"288","author":"X Yang","year":"2013","unstructured":"Yang X, Meyer K, Friedl A (2013) STAT5 and prolactin participate in a positive autocrine feedback loop that promotes angiogenesis. J Biol Chem 288:21184\u201321196. \n                    https:\/\/doi.org\/10.1074\/jbc.M113.481119","journal-title":"J Biol Chem"},{"key":"1441_CR162","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.jacc.2007.01.076.White","volume":"11","author":"D-N Masood","year":"2010","unstructured":"Masood D-N, Roach EC, Katie G, Beauregard RAK (2010) Impact of sex hormone metabolism on the vascular effects of menopausal hormone therapy in cardiovascular disease. Curr Drug Metab 11:693\u2013714. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2007.01.076.White","journal-title":"Curr Drug Metab"},{"key":"1441_CR163","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1515\/hmbci-2013-0048","volume":"18","author":"R Lyrio dos Santos","year":"2014","unstructured":"Lyrio dos Santos R, Bragan\u00e7a da Silva F, Stefanon I (2014) Sex hormones in the cardiovascular system. Horm Mol Biol Clin Invest 18:89\u2013103. \n                    https:\/\/doi.org\/10.1515\/hmbci-2013-0048","journal-title":"Horm Mol Biol Clin Invest"},{"key":"1441_CR164","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1161\/01.ATV.19.4.1034","volume":"19","author":"JK Crews","year":"1999","unstructured":"Crews JK, Khalil RA (1999) Antagonistic effects of 17 beta-estradiol, progesterone, and testosterone on Ca2 entry mechanisms of coronary vasoconstriction. Arter Thromb Vasc Biol 19:1034\u20131040","journal-title":"Arter Thromb Vasc Biol"},{"key":"1441_CR165","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1093\/emboj\/17.7.2008","volume":"17","author":"A Migliaccio","year":"1998","unstructured":"Migliaccio A, Piccolo D, Castoria G et al (1998) Activation of the Src\/p21(ras)\/Erk pathway by progesterone receptor via cross-talk with estrogen receptor. EMBO J 17:2008\u20132018. \n                    https:\/\/doi.org\/10.1093\/emboj\/17.7.2008","journal-title":"EMBO J"},{"key":"1441_CR166","first-page":"44","volume":"291","author":"JG Murphy","year":"1999","unstructured":"Murphy JG, Khalil R (1999) Decreased [Ca(2+)](i) during inhibition of coronary smooth muscle contraction by 17beta-estradiol, progesterone, and testosterone. J Pharmacol Exp Ther 291:44\u201352","journal-title":"J Pharmacol Exp Ther"},{"key":"1441_CR167","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1161\/01.RES.0000188212.57180.55","volume":"97","author":"K Wassmann","year":"2005","unstructured":"Wassmann K, Wassmann S, Nickenig G (2005) Progesterone antagonizes the vasoprotective effect of estrogen on antioxidant enzyme expression and function. Circ Res 97:1046\u20131054. \n                    https:\/\/doi.org\/10.1161\/01.RES.0000188212.57180.55","journal-title":"Circ Res"},{"key":"1441_CR168","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1056\/NEJM198510243131703","volume":"1","author":"M Stamper","year":"1985","unstructured":"Stamper M, Willett W, Colditz G, Hennekens C (1985) A prospective study of postmenopausal estrogen therapy and coronary heart disease. N Engl J Med 1:1044\u20131048","journal-title":"N Engl J Med"},{"key":"1441_CR169","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1056\/NEJM199109123251102","volume":"325","author":"MJ Stampfer","year":"1991","unstructured":"Stampfer MJ, Colditz GA, Willett WC (1991) Postmenopausal estrogen therapy and cardiovascular disease: ten-year follow-up from the Nurses\u2019 Health Study. N Engl J Med 325:756\u2013762","journal-title":"N Engl J Med"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00392-019-01441-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-019-01441-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-019-01441-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T19:14:38Z","timestamp":1582658078000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00392-019-01441-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,26]]},"references-count":169,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["1441"],"URL":"https:\/\/doi.org\/10.1007\/s00392-019-01441-x","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,26]]},"assertion":[{"value":"21 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}